News
October 1, 2012 — Effective immediately, Ziehm Imaging, a market leader for mobile C-arms, is offering operating room (OR) tables from the Swedish manufacturer Stille to complement its Ziehm Vision RFD Hybrid Edition.
October 01, 2012
News
October 1, 2012 — Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the new drug application (NDA) resubmission for Eliquis (apixaban) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (NVAF).
October 01, 2012
Technology
October 1, 2012 — SunTech Medical’s One-Piece Durable Cuffs are a new line of easily disinfected, reusable cuffs for reliable blood pressure monitoring. The highly durable cuffs feature a cost-effective, one-piece design sturdy enough for repeated use in any clinical environment.
October 01, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
October 1, 2012 — CircuLite Inc. announced that the latest data from patients enrolled in the company’s CE mark trial of the Synergy Circulatory Support System strengthened prior findings indicating that implantation with Synergy resulted in significant, sustained improvements in hemodynamics and exercise tolerance.
October 01, 2012
Technology
September 28, 2012 — MindChild Medical Inc. announced that it has received 510(k) premarketing notification clearance from the U.S. Food and Drug Administration (FDA) for its Meridian noninvasive fetal heart monitor, and anticipates entering the U.S. market with Meridian soon. Additional pre-market regulatory filings are anticipated during 2012 and 2013.
September 28, 2012News
September 28, 2012 — Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced the launch of its Quality Improvement and Value Assessment Program.
September 28, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature
The world’s first drug-eluting bioabsorbable vascular scaffold has been launched and will revolutionize the stent industry. On Sept. 25, 2012, Abbott announced the launch of its drug-eluting bioabsorbable stent, Absorb, in Europe, the Middle East and parts of Asia Pacific and Latin America. Absorb, which received CE mark certification in 2011, is used to treat coronary artery disease. Bioabsorbable stents, such as Absorb, will broaden treatment and diagnostic options, reduce the need for long-term anti-platelet therapy and reduce the risk of in-stent restenosis and thrombosis.
September 28, 2012
Technology
September 28, 2012 — Boston Scientific Corp. announced it has received U.S. Food and Drug Administration (FDA) clearance for the Emerge percutaneous transluminal coronary angioplasty (PTCA) balloon dilatation catheter, and has begun marketing the device in the United States.
September 28, 2012
Technology
Medtronic Inc. announced it has received CE mark for its Medtronic CoreValve Evolut 23 mm valve, its latest self-expanding transcatheter aortic valve implantation (TAVI) system.
September 27, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
Boston Scientific has launched the Promus Element Plus BTK (Below The Knee) everolimus-eluting stent system in European countries for the treatment of certain severe peripheral artery lesions. The drug-eluting stent (DES) has CE mark approval for both monorail and over-the-wire (OTW) versions and will be available immediately.
September 27, 2012
News
The average age of installed magnetic resonance imaging (MRI) scanners in the United States has increased from eight years in 2007 to 10.9 years in 2011, according to a new market research report by IMV Medical Information Division.
September 26, 2012
Technology
The American College of Cardiology (ACC) has certified Lumedx software as fully interoperable between four ACC NCDR registries. Lumedx, a leading provider of integrated cardiovascular imaging and information systems, is currently the only software vendor offering this level of interoperability.
September 26, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature
Abbott Vascular began its international launch of the Absorb coronary stent, the world's first drug-eluting bioresorbable vascular scaffold (BVS). It is now widely available across Europe and parts of Asia Pacific and Latin America. The Absorb is a first-of-its-kind device for the treatment of coronary artery disease (CAD).
September 26, 2012
News
September 25, 2012 — Patients are often aggressively treated with anticoagulants, or blood thinners, to help prevent pulmonary emboli from forming, but a study published in the September 2012 issue of the Journal of the American Academy of Orthopaedic Surgeons indicates that some blood clots being identified by today's sensitive testing methods may not require aggressive treatments.
September 25, 2012
Feature
Sept. 25, 2012 — America's healthcare system has become too complex and costly to continue business as usual, says a new report from the Institute of Medicine. Inefficiencies, an overwhelming amount of data and other economic and quality barriers hinder progress in improving health and threaten the nation's economic stability and global competitiveness, the report says. However, the knowledge and tools exist to put the health system on the right course to achieve continuous improvement and better quality care at lower cost, added the committee that wrote the report.
September 25, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now